New office's address :
9 avenue Mac Mahon, 75017 Paris - Métro Etoile
Some treatments block the specific mechanisms of certain cancer cells.
The most commonly used is Herceptin® (trastuzumab) which blocks the cell proliferation of tumours which have an overexpression of the HER2 receptor (10 to 15 % of breast cancers).
This medication has enabled major progress by significantly increasing the cure rate for cancers which have this receptor.